Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma by Mason, Robert, Dearden, Helen C., Nguyen, Bella, Soon, Jennifer A., Smith, Jessica Louise, Randhawa, Manreet, Mant, Andrew, Warburton, Lydai, Lo, Serigne, Meniawy, Tarek, Guminski, Alexander, Parente, Phillip, Ali, Sayed, Haydon, Andrew, Long, Georgina V., Carlino, Matteo S., Millward, Michael, Atkinson, Victoria G., Menzies, Alexander M.

Get full text